Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as ...

Abbott Park, Illinois Saturday, March 29, 2025, 13:00 Hrs [IST] ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...